EUVIMEDEUVIMED entdecken
Crossref

A small molecule K-3 promotes PDX1 expression and potentiates the differentiation of pluripotent stem cells into insulin-producing pancreatic β cells

Tatsuya Yano, Yukihiro Shimaya, Takayuki Enomoto, Toshihiro Kiho, Satoshi Komoriya, Ryutaro Nakashima, Nobuaki Shiraki, Shoen Kume iD

Stem Cells · 2025

DOI: 10.1093/stmcls/sxae075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells, 2025. Verfasst von Tatsuya Yano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Daiichi Sankyo Co., Ltd., Shinagawa-ku, Tokyo 140-8710, Japan. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Trans-Activators, Cell Differentiation, Homeodomain Proteins. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin-producing pancreatic β-like cells derived from human pluripotent stem cells (PSCs) are anticipated as a novel cell source for cell replacement therapy for patients with diabetes. Here, we describe the identification of small molecule compounds that promote the differentiation of the PSCs into insulin-producing cells by high throughput screening with a chemical library composed of 55 000 compounds. The initial hit compound K-1 and one derivative K-3 increased the proportion of PSC-derived insulin-positive endocrine cells and their glucose-stimulated insulin secretory (GSIS) functions. K-3 preferentially acts on stage 3 pancreatic progenitor cells and increases the population expressing high levels of PDX1. As a result, the ratios of the PSC-derived PDX1/NKX6.1 double-positive endocrine progenitor and INS/NKX6.1 double-positive mono-hormonal endocrine cells were increased. K-3 enhances the expression of functional pancreatic β cell markers and affects biological processes concerning organ development. K-3 also increased the yield of endocrine cells at the end of stage 5. The novel compound is a beneficial new tool for efficiently generating PSC-derived insulin-producing cells with high functionality and differentiation efficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsTrans-ActivatorsCell DifferentiationHomeodomain ProteinsPluripotent Stem CellsHumansInsulinSmall Molecule LibrariesAnimals

Stichwörter der Autor:innen

PDX1chemical screeningdifferentiationendocrine progenitorinsulinpancreatic progenitorpluripotent stem cells

Substanzen

pancreatic and duodenal homeobox 1 proteinTrans-ActivatorsHomeodomain ProteinsInsulinSmall Molecule Libraries

Autor:innen und Institutionen

  • Daiichi Sankyo Co., Ltd., Shinagawa-ku, Tokyo 140-8710, Japan.
  • Department of Life Science and Technology, School of Life Science and Technology, Institute of Science Tokyo, Yokohama, Kanagawa 226-8501, Japan.
  • Bioscience Center, Research Infrastructure Management Center, Institute of Science Tokyo, Yokohama, Kanagawa 226-8501, Japan.

ORCID-Profile: Shoen Kume

Zitieren

APA

Yano, T., Shimaya, Y., Enomoto, T., Kiho, T., Komoriya, S., Nakashima, R., Shiraki, N., & Kume, S. (2025). A small molecule K-3 promotes PDX1 expression and potentiates the differentiation of pluripotent stem cells into insulin-producing pancreatic β cells. Stem Cells. https://doi.org/10.1093/stmcls/sxae075

Vancouver

Yano T, Shimaya Y, Enomoto T, Kiho T, Komoriya S, Nakashima R, et al. A small molecule K-3 promotes PDX1 expression and potentiates the differentiation of pluripotent stem cells into insulin-producing pancreatic β cells. Stem Cells. 2025. doi:10.1093/stmcls/sxae075

BibTeX
@article{Yano2025,
  author = {Yano, Tatsuya and Shimaya, Yukihiro and Enomoto, Takayuki and Kiho, Toshihiro and Komoriya, Satoshi and Nakashima, Ryutaro and Shiraki, Nobuaki and Kume, Shoen},
  title = {A small molecule K-3 promotes PDX1 expression and potentiates the differentiation of pluripotent stem cells into insulin-producing pancreatic β cells},
  journal = {Stem Cells},
  year = {2025},
  doi = {10.1093/stmcls/sxae075}
}
Kostenlos starten →